PDF (8.6 MB)

Cite

Collect

Letter to the Editor | Open Access

Ortner's syndrome secondary to aortic arch aneurysm after SARS-CoV-2 infection

Zhi-Qing FU, Shan LI()

Department of Cardiology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China

Show Author Information

References

[1]

Hurtarte Sandoval AR, Carlos Zamora R, Gómez Carrasco JM, et al. Ortner’s syndrome: a case report and review of the literature. BMJ Case Rep 2014; 2014: bcr2013202900.

Crossref Google Scholar

[2]

Verma S, Talwar A, Talwar A, et al. Ortner’s syndrome: a systematic review of presentation, diagnosis and management. Intractable Rare Dis Res 2023; 12: 141−147.

Crossref Google Scholar

[3]

Fujimura N, Xiong J, Kettler EB, et al. Metformin treatment status and abdominal aortic aneurysm disease progression. J Vasc Surg 2016; 64: 46−54. e8.

Crossref

[4]

Itoga NK, Rothenberg KA, Suarez P, et al. Metformin prescription statu and abdominal aortic aneurysm disease progression in the U.S. veteran population. J Vasc Surg 2019; 69: 710-716. e3.

Crossref

[5]

Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010; 52: 539−548.

Crossref Google Scholar

[6]

Bozzani A, Arici V, Franciscone M, et al. COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture. J Vasc Surg 2022; 75: 387−388.

Crossref Google Scholar

[7]

Ramandi A, Akbarzadeh MA, Khaheshi I, et al. Aortic dissection and Covid-19; a comprehensive systematic review. Curr Probl Cardiol 2023; 48: 101129.

Crossref Google Scholar

[8]

Bozzani A, Arici V, Ticozzelli G, et al. Sudden rupture of abdominal aortic aneurysm in COVID19 patients. J Endovasc Ther 2023; 30: 296−301.

Crossref Google Scholar

[9]

Rinaldi LF, Marazzi G, Marone EM. Endovascular treatment of a ruptured pararenal abdominal aortic aneurysm in a patient with coronavirus disease 2019: suggestions and case report. Ann Vasc Surg 2020; 66: 18−23.

Crossref Google Scholar

[10]

Thompson A, Cooper JA, Fabricius M, et al. An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg 2010; 52: 55−61.e2.

Crossref

[11]

Bhak RH, Wininger M, Johnson GR, et al. Factors associated with small abdominal aortic aneurysm expansion rate. JAMA Surg 2015; 150: 44−50.

Crossref Google Scholar

[12]

Shukla AK, Banerjee M. Angiotensin-converting-enzyme 2 and renin-angiotensin system inhibitor in COVID-19: an update. High Blood Press Cardiovasc Prev 2021; 28: 129−139.

Crossref Google Scholar

[13]

Xu B, Li G, Guo J, et al. Angiotensin-converting enzyme 2, coronavirus diseases 2019, and abdominal aortic aneurysms. J Vasc Surg 2021; 74: 1740−1751.

Crossref Google Scholar

[14]

Borrelli V, Sterpetti AV, Coluccia P, et al. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. J Surg Res 2001; 100: 154−160.

Crossref Google Scholar

[15]

Cucina A, Borrelli V, Di Carlo A, et al. Thrombin induces production of growth factor from aortic smooth muscle cells. J Surg Res 1999; 82: 61−66.

Crossref Google Scholar

[16]

Bissacco D, Franchin M, Piffaretti G, et al. Impact of COVID-19 on aortic operations. Semin Vasc Surg 2021; 34: 37−42.

Crossref Google Scholar

Journal of Geriatric Cardiology

Volume 22 Issue 2,
February 2025

Pages 274-276

DOI: 10.26599/1671-5411.2025.02.005

Cite this article:

FU Z-Q, LI S. Ortner's syndrome secondary to aortic arch aneurysm after SARS-CoV-2 infection. Journal of Geriatric Cardiology, 2025, 22(2): 274-276. https://doi.org/10.26599/1671-5411.2025.02.005